Founded in 2019, Prescribe operates in Health Tech industry. Initially focused on providing users with tailored medicine plans and reminders, the company has expanded its platform to integrate telehea...
Funding stage:
Seed
Last funding:
21/03/2021
Total funding:
$134.00K+
Investors
Employee count:
20
Last 90d
20
Last 90d
Glassdoor Rating:
Prescribe: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders9
Latest Filing Date30 March 2021- Funding Events5
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Prescribe
As of 31 March 2021, Prescribe's equity is held by 9 shareholders, with the top three being Nived Narayanan, Sreeshyam C A, and Amit Kumar Verma.
Nived Narayanan holds the largest stake in Prescribe at 36.1% as of 31 March 2021.
As of 31 March 2021, founders collectively hold 84.8% equity in Prescribe.
As of 31 March 2021, investors collectively hold 15.1% equity in Prescribe.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links